These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37925819)

  • 21. Lysophosphatidic Acid Promotes Epithelial to Mesenchymal Transition in Ovarian Cancer Cells by Repressing SIRT1.
    Ray U; Roy SS; Chowdhury SR
    Cell Physiol Biochem; 2017; 41(2):795-805. PubMed ID: 28214851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydrogen sulfide attenuates cigarette smoke-induced airway remodeling by upregulating SIRT1 signaling pathway.
    Guan R; Wang J; Cai Z; Li Z; Wang L; Li Y; Xu J; Li D; Yao H; Liu W; Deng B; Lu W
    Redox Biol; 2020 Jan; 28():101356. PubMed ID: 31704583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition.
    Lee M; Kim DW; Yoon H; So D; Khalmuratova R; Rhee CS; Park JW; Shin HW
    J Allergy Clin Immunol; 2016 Jan; 137(1):87-98.e7. PubMed ID: 26342525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A SUMOylation-dependent pathway regulates SIRT1 transcription and lung cancer metastasis.
    Sun L; Li H; Chen J; Dehennaut V; Zhao Y; Yang Y; Iwasaki Y; Kahn-Perles B; Leprince D; Chen Q; Shen A; Xu Y
    J Natl Cancer Inst; 2013 Jun; 105(12):887-98. PubMed ID: 23704280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
    Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism by which SIRT1 regulates autophagy and EMT in drug-resistant oesophageal cancer cells.
    Zhang X; Dong Y; Li W; He M; Shi Y; Han S; Li L; Zhao J; Li L; Huo J; Liu X; Ji Y; Liu Q; Wang C
    Life Sci; 2024 Apr; 343():122530. PubMed ID: 38401628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of SIRT1 promotes metastasis through epithelial-mesenchymal transition in hepatocellular carcinoma.
    Hao C; Zhu PX; Yang X; Han ZP; Jiang JH; Zong C; Zhang XG; Liu WT; Zhao QD; Fan TT; Zhang L; Wei LX
    BMC Cancer; 2014 Dec; 14():978. PubMed ID: 25522783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cheng F; Su L; Yao C; Liu L; Shen J; Liu C; Chen X; Luo Y; Jiang L; Shan J; Chen J; Zhu W; Shao J; Qian C
    Cancer Lett; 2016 Jun; 375(2):274-283. PubMed ID: 26975631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition.
    Qian W; Cai X; Qian Q
    Aging (Albany NY); 2020 Mar; 12(5):4322-4336. PubMed ID: 32139663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MPP8 and SIRT1 crosstalk in E-cadherin gene silencing and epithelial-mesenchymal transition.
    Sun L; Kokura K; Izumi V; Koomen JM; Seto E; Chen J; Fang J
    EMBO Rep; 2015 Jun; 16(6):689-99. PubMed ID: 25870236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.
    Xu J; Zhu W; Xu W; Yao W; Zhang B; Xu Y; Ji S; Liu C; Long J; Ni Q; Yu X
    Curr Mol Med; 2013 Mar; 13(3):387-400. PubMed ID: 23331011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SIRT1 deacetylates KLF4 to activate Claudin-5 transcription in ovarian cancer cells.
    Zhang X; Chen J; Sun L; Xu Y
    J Cell Biochem; 2018 Feb; 119(2):2418-2426. PubMed ID: 28888043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells.
    Zhang L; Wang X; Chen P
    BMC Cancer; 2013 Jun; 13():290. PubMed ID: 23768087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
    Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
    Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactate Increases Renal Cell Carcinoma Aggressiveness through Sirtuin 1-Dependent Epithelial Mesenchymal Transition Axis Regulation.
    Miranda-Gonçalves V; Lameirinhas A; Macedo-Silva C; Lobo J; C Dias P; Ferreira V; Henrique R; Jerónimo C
    Cells; 2020 Apr; 9(4):. PubMed ID: 32340156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SIRT1 inhibition in pancreatic cancer models: contrasting effects in vitro and in vivo.
    Oon CE; Strell C; Yeong KY; Östman A; Prakash J
    Eur J Pharmacol; 2015 Jun; 757():59-67. PubMed ID: 25843411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
    Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR
    Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of SIRT1 Gene on Epithelial-Mesenchymal Transition of Human Prostate Cancer PC-3 Cells.
    Cui Y; Li J; Zheng F; Ouyang Y; Chen X; Zhang L; Chen Y; Wang L; Mu S; Zhang H
    Med Sci Monit; 2016 Feb; 22():380-6. PubMed ID: 26847404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oleuropein inhibits migration ability through suppression of epithelial-mesenchymal transition and synergistically enhances doxorubicin-mediated apoptosis in MCF-7 cells.
    Choupani J; Alivand MR; M Derakhshan S; Zaeifizadeh M; S Khaniani M
    J Cell Physiol; 2019 Jun; 234(6):9093-9104. PubMed ID: 30317622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NAD
    Jiang Y; Luo Z; Gong Y; Fu Y; Luo Y
    Oncogene; 2023 Mar; 42(11):808-824. PubMed ID: 36690678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.